Bacillus Calmette–Guerin (BCG) intravesical instillation therapy is the most effective adjuvant therapy for bladder cancer after transurethral resection of bladder tumor. However, Bacillus Calmette–Guerin therapy is associated with a high risk o...
1.叶定伟.非肌层浸润性膀胱癌膀胱灌注治疗专家共识（2021版） [J]. 中华肿瘤杂志，2021,43(10).2.Wong HC, Jeng EK, Rhode PR. The IL-15-based superagonist ALT-803 promotes the antigen-independent conversion of memory CD8+ T cells into innate-like effector cells with antitumor activity. Oncoimmun...
Since the turn of the 20th century Bacillus Calmette-Guerin (BCG) treatment for non-muscle invasive bladder cancer (NMIBC) has been in and out of favour. However, only a small proportion of patients, as low as 16%, complete what is seen as a gold standard treatment. To understand why ...
E16600- Interim results from a phase II study of tislelizumab combined with radiotherapy as bladder-preserving treatment for patients with high-risk non-muscle-invasive bladder cancer (HR NMIBC) unresponsive to bacillus Calm...
Chicago-Patients with carcinoma in situ or recurrent Ta, Tis, or T1 bladdercancer are at increased risk of dying of the disease within 5 years unlessthey achieve a complete response with bacille Calmette-Guérin therapy,say researchers from the Southwest Oncology Group....
Urdaneta G,Solsona E, et al.Intravesical Chemotherapy and BCG for the Treatment of Bladder Cancer:Evidence and Opinion. European Urology . 2008Guillermo Urdaneta,Eduardo Solsona,Juan Palou.Intravesical Chemotherapy and BCG for the Treatment of Bladder Cancer: Evidence and Opinion ...
-a treatment that controlssuperficial bladder cancer, particularlycarcinoma in situ. I was surprised tolearn that an ancient vaccine, originallydesigned to prevent tuberculosis (TB), isemployed for a completely unrelatedindication and is the current treatment ofchoice for bladder cancer. I thought that...
At present, BCG intravesical instillation therapy is considered a very effective treatment modality for superficial bladder cancer. In this paper, the present status of BCG intravesical treatment was discussed along with speculation on the future directions of BCG treatment for this malignant disease....
Influence of residual volume of syringe on the effect ofBacillus Calmette-Guerinvaccination; 注射器死腔残留量对卡介苗接种免疫效果的影响 3. A Comparison of IntravesicalBacillus Calmette-GuerinVersus Mitomycin C for Superficial Bladder Cancer of Chinese Postoperatively on Recurrence and Toxicity(Meta-Analysis...
1. ANTI-ADENOVIRUS ANTIBODY LEVELS PREDICT NADOFARAGENE FIRADENOVEC RESPONSE DURABILITY IN BCG-UNRESPONSIVE NON-MUSCLE-INVASIVE BLADDER CANCER: RESULTS FROM A PHASE 3 CLINICAL TRIAL 38 2.RATIONALE FOR INTRAVESICAL IFNA2 REPLACEM...